INNOVUS PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year Three
INNOVUS PHARMACEUTICALS, INC. had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $657.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2019-11-14
- 2019-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $657.00K.
- 2019-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $657.00K.
- 2019-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $657.00K.
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $657.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2019-09-30 | $657.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $657.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $657.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $657.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $628.53K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $628.52K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $629.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $629.00K 10-K · filed 2018-04-02 |
| 2017-09-30 | $629.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $629.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $629.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $630.00K 10-K · filed 2017-03-09 |
| 2016-09-30 | $712.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $651.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $651.00K 10-Q · filed 2016-05-16 |